# Medicardia Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medicardia-health-2

- Industry: Healthcare
- Headquarters: Kenosha, US
- Website: www.medicardiahealth.com
- Total disclosed funding: $3M
- Latest round: Series A (Oct 21, 2021)
- Investors on record: 2

## About

Medicardia Health, Inc specializes in developing advanced healthcare technology solutions aimed at enhancing patient outcomes and operational efficiencies within the healthcare industry.Founded in 2018 and headquartered in Kenosha, US, Medicardia Health, Inc focuses on leveraging technology to improve healthcare delivery. The company raised USD 3.000 mn in Series A funding on October 21, 2021, from investors including Cream City Venture Capital and Milwaukee Venture Partners. The founders, David Geddam and Indrajit Choudhuri, bring significant experience in technology and healthcare, with Geddam previously involved in other health tech ventures.Medicardia Health, Inc offers a suite of innovative healthcare technology products and services aimed at addressing critical operational challenges in the healthcare sector. Their offerings include advanced solutions that enhance efficiency, reduce costs, and improve overall patient engagement. The company primarily serves healthcare providers and institutions across North America and Europe, facilitating better resource management and patient interaction through their technology-driven solutions.The company generates revenue through a combination of subscription services and direct sales, focusing on B2B partnerships and direct-to-consumer sales. Clients typically engage through subscription agreements, which grant access to their comprehensive suite of services while one-time product purchases are also available. This structured revenue model supports predictable cash flow and is designed to remain competitive in the market.Following the recent Series A financing of USD 3.000 mn raised in October 2021, Medicardia Health, Inc plans to accelerate the development of its technology platform. Upcoming enhancements will include integration for implantable devices, advanced imaging capabilities, a research platform, and a proprietary clinical intelligence engine. The company intends to further expand its presence into new geographic markets, focusing on regions where healthcare technology adoption is on the rise.

## Funding rounds

- Series A, Oct 21, 2021, $3M — Cream City Venture Capital, Milwaukee Venture Partners

## Investors

- Cream City Venture Capital (https://capitalatlas.ai/funds/cream-city-venture-capital) — Series A
- Milwaukee Venture Partners (https://capitalatlas.ai/funds/milwaukee-venture-partners) — Series A